JP2024516698A5 - - Google Patents
Info
- Publication number
- JP2024516698A5 JP2024516698A5 JP2023567897A JP2023567897A JP2024516698A5 JP 2024516698 A5 JP2024516698 A5 JP 2024516698A5 JP 2023567897 A JP2023567897 A JP 2023567897A JP 2023567897 A JP2023567897 A JP 2023567897A JP 2024516698 A5 JP2024516698 A5 JP 2024516698A5
- Authority
- JP
- Japan
- Prior art keywords
- ilt7
- binding protein
- seq
- composition according
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163183886P | 2021-05-04 | 2021-05-04 | |
| US63/183,886 | 2021-05-04 | ||
| US202163197789P | 2021-06-07 | 2021-06-07 | |
| US63/197,789 | 2021-06-07 | ||
| US202163242768P | 2021-09-10 | 2021-09-10 | |
| US63/242,768 | 2021-09-10 | ||
| US202163249953P | 2021-09-29 | 2021-09-29 | |
| US63/249,953 | 2021-09-29 | ||
| US202263326424P | 2022-04-01 | 2022-04-01 | |
| US63/326,424 | 2022-04-01 | ||
| PCT/US2022/027620 WO2022235758A1 (en) | 2021-05-04 | 2022-05-04 | Methods of treatment of autoimmune disorders using ilt7 binding proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516698A JP2024516698A (ja) | 2024-04-16 |
| JP2024516698A5 true JP2024516698A5 (https=) | 2025-05-13 |
Family
ID=82021082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567897A Pending JP2024516698A (ja) | 2021-05-04 | 2022-05-04 | Ｉｌｔ７結合タンパク質を使用する、自己免疫疾患の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240287176A1 (https=) |
| EP (1) | EP4333877A1 (https=) |
| JP (1) | JP2024516698A (https=) |
| KR (1) | KR20240004451A (https=) |
| AU (1) | AU2022270101A1 (https=) |
| BR (1) | BR112023023036A2 (https=) |
| CA (1) | CA3217278A1 (https=) |
| IL (1) | IL308132A (https=) |
| MX (1) | MX2023013015A (https=) |
| WO (1) | WO2022235758A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017231833B2 (en) | 2016-03-10 | 2024-03-14 | Viela Bio, Inc. | ILT7 binding molecules and methods of using the same |
| AR130042A1 (es) * | 2022-07-27 | 2024-10-30 | Viela Bio Inc | Formulaciones que comprenden una proteína de unión al transcripto 7 similar a inmunoglobulina (ilt7) |
| EP4593823A1 (en) * | 2022-09-30 | 2025-08-06 | Abbvie Inc. | Methods of treating hidradenitis suppurativa |
| WO2024126431A1 (en) * | 2022-12-12 | 2024-06-20 | Horizon Therapeutics Ireland Dac | Anti-ilt7 binding agents for the treatment and prevention of myositis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ616992A (en) * | 2005-12-20 | 2015-07-31 | Sbi Biotech Co Ltd | Anti-ilt7 antibody |
| US20110311558A1 (en) * | 2008-12-01 | 2011-12-22 | The Board Of Regents Of The University Of Texas System | Recombinant Bone Marrow Stromal Antigen-2 in the Treatment of Autoimmune Diseases |
| CA2772921A1 (en) * | 2009-09-03 | 2011-03-10 | Medimmune, Llc | Type 1 interferon diagnostic |
| AU2017231833B2 (en) | 2016-03-10 | 2024-03-14 | Viela Bio, Inc. | ILT7 binding molecules and methods of using the same |
| IL293572A (en) | 2019-12-06 | 2022-08-01 | Viela Bio Inc | Treatment methods using ilt7 binding proteins |
-
2022
- 2022-05-04 MX MX2023013015A patent/MX2023013015A/es unknown
- 2022-05-04 WO PCT/US2022/027620 patent/WO2022235758A1/en not_active Ceased
- 2022-05-04 BR BR112023023036A patent/BR112023023036A2/pt unknown
- 2022-05-04 AU AU2022270101A patent/AU2022270101A1/en active Pending
- 2022-05-04 KR KR1020237037954A patent/KR20240004451A/ko active Pending
- 2022-05-04 IL IL308132A patent/IL308132A/en unknown
- 2022-05-04 EP EP22730332.8A patent/EP4333877A1/en active Pending
- 2022-05-04 CA CA3217278A patent/CA3217278A1/en active Pending
- 2022-05-04 JP JP2023567897A patent/JP2024516698A/ja active Pending
- 2022-05-04 US US18/558,505 patent/US20240287176A1/en active Pending